Despite the current data available, a consensus on the optimal pre-transplant AFP level to predict post-transplant survival is yet to be determined, and many proposed scores for transplant candidacy have proposed different AFP cutoffs based on tumor size and number [18,21,22,23]. The gene discussed is AFP; the disease is neoplasm.